Details for Patent: 5,478,852
✉ Email this page to a colleague
Summary for Patent: 5,478,852
| Title: | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus |
| Abstract: | Novel methods of using thiazolidinone derivatives and related antihyperglycemic agents to treat populations experiencing impaired glucose intolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus (NIDDM) and complications arising therefrom are disclosed. |
| Inventor(s): | Jerrold Olefsky, Tammy Antonucci, Dean Lockwood, Rebecca Norris |
| Assignee: | Daiichi Sankyo Co Ltd |
| Application Number: | US08/293,899 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 5,478,852
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,478,852
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 198045 | ⤷ Start Trial | |||
| Austria | 303147 | ⤷ Start Trial | |||
| Austria | 376829 | ⤷ Start Trial | |||
| Austria | 489952 | ⤷ Start Trial | |||
| Australia | 1770997 | ⤷ Start Trial | |||
| Australia | 1771097 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
